Global High-Priority Regulatory Events — February 19, 2026

20-02-2026

20-02-2026

20-02-2026

20-02-2026

20-02-2026

20-02-2026

NOV Inc. filed an 8-K on February 20, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any quantitative data such as compensation amounts are disclosed. No positive or negative metrics, board impacts, or scheduled events are mentioned.

• ·Filing Accession Number: 0001193125-26-060618
• ·File Size: 144 KB
• ·Critical missing information: Officer name, title (e.g., CEO/CFO), action (appointment/resignation), reason (retirement/performance), effective date, compensation details, board composition impact, succession signals - all NOT_DISCLOSED
• ·Data completeness: LOW (<50% key data available for leadership analysis)

20-02-2026

20-02-2026

BRUKER CORP filed an 8-K on 2026-02-20 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 8.01 for other events. No specific details such as key position affected (e.g., CEO, CFO), appointment or resignation status, reasons, timing, or any quantitative data are disclosed. This filing provides no directional financial or performance metrics, positive or negative.

20-02-2026

Autoliv Inc filed a Form 8-K on February 20, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.

20-02-2026

20-02-2026

MidWestOne Financial Group, Inc. filed an 8-K on February 20, 2026, disclosing under Item 2.01 the completion of an acquisition or disposition of assets, Item 3.01 notice of delisting or failure to satisfy listing standards, Item 3.03 material modifications to rights of security holders, Item 5.01 changes in control of the registrant, Item 5.02 departures of directors/officers or elections/appointments with compensatory arrangements, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 financial statements and exhibits. No quantitative metrics, deal values, parties, premiums, synergies, or financial impacts were disclosed. The filing signals a transformative corporate event but lacks details on structure or outcomes.

20-02-2026

20-02-2026

Nicolet Bankshares Inc filed an 8-K on February 20, 2026, reporting the completion of an acquisition or disposition of assets under Item 2.01. The filing also covers departures or elections of directors/officers and compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. No quantitative metrics, transaction values, parties involved, or performance comparisons are disclosed.

20-02-2026

Oak Woods Acquisition Corp filed an 8-K on 2026-02-20 (AccNo: 0001213900-26-018541) under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No merger/acquisition details, quantitative metrics, parties involved, or strategic rationale are disclosed in the filing summary. Sector not specified, with no positive or negative financial changes reported.

20-02-2026

D. Boral Acquisition I Corp., a likely SPAC based on its name, filed an 8-K on 2026-02-20 under Item 8.01 Other Events related to a merger/acquisition event. No deal structure, parties involved, financial terms, strategic rationale, or quantitative metrics are explicitly disclosed in the provided filing details. Critical transaction specifics remain NOT_DISCLOSED, limiting assessment of impact.

20-02-2026

20-02-2026

20-02-2026

Green Thumb Industries Inc. filed a Form 8-K on February 20, 2026, disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, accompanied by Regulation FD disclosure under Item 7.01 and financial statements/exhibits under Item 9.01. No specific transaction details, dollar values, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics provided.

20-02-2026

Citi Trends Inc filed an 8-K on 2026-02-20 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.

20-02-2026

20-02-2026

BWX Technologies, Inc. filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included, but specific details on the officer, position, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or governance impacts are provided in the filing summary.

20-02-2026

Sonoco Products Co filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 referencing attached financial statements and exhibits. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for change, or timing are provided. Critical information such as names, titles, and context is NOT_DISCLOSED, limiting assessment of governance or market impact.

20-02-2026

OFF THE HOOK YS INC. filed an 8-K on February 20, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction size, or financial impacts disclosed in the provided information. No quantitative metrics, comparisons, or scheduled events are mentioned.

20-02-2026

Nucor Corp filed an 8-K on February 20, 2026 (AccNo: 0001193125-26-060448, Size: 154 KB) disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections of directors, appointments of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details such as names, positions, reasons, timing, or financial terms are disclosed.

• ·AccNo: 0001193125-26-060448
• ·Filing size: 154 KB
• ·Critical missing information: Officer/director names and titles, specific action (appointment/resignation/retirement), reasons for change, effective dates, internal/external status, compensation details, board composition changes, succession planning signals - impacts analysis quality
• ·Data completeness: LOW (<50%) - only high-level Item descriptions available, no substantive facts from filing content

20-02-2026

20-02-2026

Vistagen Therapeutics, Inc. filed an 8-K on 2026-02-20 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are provided in the available information. No positive or negative metrics, board composition changes, or governance implications are explicitly stated.

20-02-2026

Moleculin Biotech, Inc. filed an 8-K on February 20, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. This multi-item filing signals potentially significant corporate actions such as financing or partnerships, common in biotech, but no quantitative details like transaction values, share counts, or financial impacts are disclosed. No positive or negative metrics are provided, resulting in purely informational disclosure.

20-02-2026

INFLECTION POINT ACQUISITION CORP. IV filed an 8-K on 2026-02-20 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits) related to a Merger/Acquisition event. No specific deal structure, parties beyond the filer, valuation, financial terms, or quantitative metrics are disclosed. No positive or negative performance indicators, comparisons, or scheduled events are mentioned.

20-02-2026

FIRST MID BANCSHARES, INC. filed an 8-K on 2026-02-20 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, transaction value, terms, or financial impact are provided.

20-02-2026

ACNB Corp filed an 8-K on February 20, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

20-02-2026

Wheeler Real Estate Investment Trust, Inc. filed a Form 8-K on 2026-02-20 disclosing entry into a material definitive agreement under Item 1.01 and changes involving departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers under Item 5.02. This is a multi-item mandatory filing with no financial metrics, transaction sizes, personnel names, or other quantitative details provided. No positive or negative performance metrics are mentioned.

20-02-2026

CMS Energy Corp filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected position, individual names, reasons for change, timing, or quantitative data are disclosed.

20-02-2026

Coca Cola Co filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, timing, or any quantitative metrics are disclosed.

20-02-2026

VIP Play, Inc. filed an 8-K on 2026-02-20 disclosing a creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03 and departure of directors or certain officers, election/appointment of directors/officers, or compensatory arrangements under Item 5.02. Item 9.01 references financial statements and exhibits. No specific details on leadership changes, financial terms, reasons, names, positions, or quantitative metrics are disclosed.

20-02-2026

Kirby Corp filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 referencing financial statements and exhibits. Specific details including the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the filing summary.

20-02-2026

ERIE INDEMNITY CO filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements and exhibits under Item 9.01. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for change, and any quantitative data such as compensation amounts are NOT_DISCLOSED. No positive or negative metrics, period-over-period comparisons, or financial impacts are mentioned.

20-02-2026

CHOICE HOTELS INTERNATIONAL INC /DE filed an 8-K on 2026-02-20 (AccNo: 0001628280-26-010118, Size: 145 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons for change, or timing are explicitly stated. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.

20-02-2026

Exelon Corp filed an 8-K on 2026-02-20 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, accompanied by exhibits under Item 9.01. No specific details, dollar values, financial impacts, positive or negative metrics, or strategic context are disclosed in the provided filing summary. This multi-item filing signals potentially material developments but lacks quantitative data for assessment.

20-02-2026

SRx Health Solutions, Inc. filed an 8-K on 2026-02-20 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, with transfer of listing implications. Item 9.01 includes financial statements and exhibits. No financial metrics, transaction values, or specific reasons for delisting are disclosed.

• ·AccNo: 0001493152-26-007565
• ·File Size: 280 KB
• ·Sector: NOT_DISCLOSED

20-02-2026

Sigyn Therapeutics, Inc. filed a Form 8-K on February 20, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with exhibits provided under Item 9.01. This multi-item filing signals a potentially strategic transaction but introduces equity dilution risk with no offsetting positive metrics disclosed. No quantitative details such as transaction values, share counts, or financial impacts are provided.

20-02-2026

Alternus Clean Energy, Inc. filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for change, timing, or any quantitative impacts are disclosed in the provided filing information. Sector is not specified.

20-02-2026

Reliability Inc filed an 8-K on 2026-02-20 reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits (AccNo: 0001493152-26-007579, file size 6 MB). This is a multi-item filing with no specific details provided on the agreement, events, parties, financial terms, or impacts. No quantitative metrics, comparisons, or forward-looking statements are disclosed.

20-02-2026

Summit Networks Inc. filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on affected positions, individuals, reasons for change, timing, or quantitative data are disclosed.

20-02-2026

Hasbro, Inc. filed an 8-K on February 20, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are provided.

20-02-2026

Serve Robotics Inc. /DE/ filed an 8-K on 2026-02-20 announcing the completion of an acquisition or disposition of assets under Item 2.01, with financial statements and exhibits provided under Item 9.01. No specific details on transaction parties, structure, valuation, or strategic rationale are disclosed. No quantitative metrics, positive or negative changes, or performance comparisons are mentioned.

• ·Filing Accession Number: 0001213900-26-018806
• ·File Size: 1 MB
• ·Sector: NOT_DISCLOSED

20-02-2026

AXIS CAPITAL HOLDINGS LTD filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, effective dates, or any quantitative impacts are disclosed.

20-02-2026

Southern California Edison Co filed an 8-K on 2026-02-20 reporting Item 1.01 entry into a material definitive agreement, Item 1.02 termination of a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, financial impacts, or specific terms are disclosed. This multi-item filing reflects both new commitments and terminations with unclear net effects.

20-02-2026

MSP Recovery, Inc. filed a Form 8-K on February 20, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details, dollar values, personnel names, transaction terms, financial metrics, or impacts are disclosed in the provided filing summary.

20-02-2026

KALA BIO, Inc. filed an 8-K on February 20, 2026 (AccNo: 0001829126-26-001534), disclosing information under Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any quantitative data such as compensation amounts are explicitly stated. Sector is not specified, and no positive or negative financial metrics are mentioned.

• ·Event date: February 20, 2026
• ·Sector: not specified

20-02-2026

Cousins Properties Inc filed a Form 8-K on 2026-02-20 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, obligation size, strategic context, or financial impacts disclosed in the provided summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

20-02-2026

Skye Bioscience, Inc. filed an 8-K on February 20, 2026 (AccNo: 0001628280-26-010186), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, appointment or resignation status, reasons for the change, or any compensatory arrangements are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

20-02-2026

Cohen & Co Inc. filed an 8-K on 2026-02-20 disclosing under Item 1.01 entry into a material definitive agreement, while under Item 1.02 reporting termination of another material definitive agreement. Item 9.01 provides for financial statements and exhibits. The simultaneous entry and termination suggest strategic shifts, but no details on terms, impacts, or net effects are disclosed.

20-02-2026

OFS Capital Corp filed an 8-K on 2026-02-20 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing involving both new commitments and terminations, but no details on agreements, parties, terms, values, or impacts are disclosed. No quantitative metrics, period-over-period changes, or scheduled events are mentioned.

20-02-2026

Domino's Pizza Inc filed a Form 8-K on 2026-02-20 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions affected, reasons for change, or timing were provided in the filing summary. No quantitative financial metrics, performance comparisons, or other material data were disclosed.

20-02-2026

Hecla Mining Co/DE/ filed an 8-K on 2026-02-20 (AccNo: 0001437749-26-004900) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key position affected, names, appointment or resignation status, reasons, timing, or quantitative data are disclosed in the provided information. No positive or negative metrics, scheduled events, or governance impacts are mentioned.

20-02-2026

Five9, Inc. filed an 8-K on 2026-02-20 reporting entry into a Material Definitive Agreement under Item 1.01, with Financial Statements and Exhibits under Item 9.01. This is a multi-item mandatory disclosure with no specific transaction details, parties, dollar values, or financial impacts provided. No positive or negative metrics are disclosed.

20-02-2026

TriSalus Life Sciences, Inc. filed an 8-K on February 20, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, events, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This is a multi-item filing with no period-over-period comparisons, positive or negative metrics mentioned.

20-02-2026

Abpro Holdings, Inc. filed an 8-K on 2026-02-20 under Item 3.01 announcing a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No quantitative financial metrics, positive developments, or offsetting factors were disclosed. This event indicates a failure to meet listing requirements, with no details on reasons, timing, or impacts provided.

• ·Single-item 8-K filing (Item 3.01 only)
• ·Accession Number: 0001213900-26-018819
• ·File size: 243 KB
• ·Sector: NOT_DISCLOSED

20-02-2026

PulteGroup Inc/MI/ filed an 8-K on February 20, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 references financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are provided.

20-02-2026

RXO, Inc. filed a Form 8-K on February 20, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 8.01 other events, with exhibits under Item 9.01. This is a multi-item mandatory disclosure for Items 1.01 and 2.03. No specific details on transaction value, parties, financial impact, or other metrics are disclosed.

20-02-2026

Farmer Brothers Co filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, or any quantitative data are provided. No positive or negative metrics are mentioned.

20-02-2026

Buckle Inc filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on positions affected, names, reasons for change, or any quantitative metrics are disclosed.

20-02-2026

Exxon Mobil Corp filed an 8-K on 2026-02-20 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names, appointment or resignation status, reasons, or timing are disclosed. No quantitative data, financial metrics, or governance implications are provided.

20-02-2026

MITEK SYSTEMS INC filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for the change, or any quantitative impacts are disclosed. No positive or negative metrics are provided in the filing summary.

20-02-2026

Gran Tierra Energy Inc. filed an 8-K on February 20, 2026 (AccNo: 0001104659-26-018158), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, parties, impacts, or metrics are disclosed.

• ·Filing size: 1 MB
• ·Sector: NOT_DISCLOSED

20-02-2026

Scilex Holding Co filed an 8-K on February 20, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, share counts, or financial impacts are disclosed.

20-02-2026

AMERICAN COASTAL INSURANCE Corp filed an 8-K on 2026-02-20 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) with exhibits under Item 9.01. No specific details on the key position affected, individual involved, reason for change, or any financial metrics are disclosed. This appears to be an informational filing with no quantified positive or negative impacts reported.

20-02-2026

Eastman Chemical Co filed a Form 8-K on 2026-02-20 under Item 1.01 disclosing entry into a material definitive agreement, Item 8.01 for other events, and Item 9.01 for financial statements and exhibits. This is a multi-item filing, but no specific details on the agreement, events, transaction size, financial impacts, or metrics are disclosed. The announcement signals potentially significant strategic developments, though lacking quantification or context for directional assessment.

20-02-2026

AMERICAN STATES WATER CO filed an 8-K on 2026-02-20 disclosing entry into a Material Definitive Agreement under Item 1.01, with Financial Statements and Exhibits attached under Item 9.01. No specific details on the agreement, transaction value, parties involved, financial impacts, or strategic rationale are disclosed in the provided filing summary. No quantitative metrics, period-over-period comparisons, positive or negative changes, or scheduled events are mentioned.

20-02-2026

Faraday Future Intelligent Electric Inc. filed a Form 8-K on 2026-02-20 under Item 3.03 disclosing material modifications to rights of security holders and under Item 5.03 reporting amendments to articles of incorporation or bylaws or a change in fiscal year. Item 9.01 provides for financial statements and exhibits. No specific details, numerical values, positive or negative impacts, or further context on the changes are disclosed in the provided filing summary.

• ·AccNo: 0001213900-26-018808
• ·File Size: 295 KB

20-02-2026

SOUTHSIDE BANCSHARES INC filed an 8-K on February 20, 2026 (AccNo: 0000705432-26-000029), disclosing developments under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were provided. No specific details on affected positions, individuals, reasons for changes, or quantitative impacts are disclosed.

20-02-2026

Atossa Therapeutics, Inc. filed a Form 8-K on February 20, 2026, reporting under Item 1.01 the entry into a new material definitive agreement, potentially signaling strategic progress. However, under Item 1.02, it disclosed the termination of a prior material definitive agreement, which may introduce uncertainty or costs. Item 9.01 includes financial statements and exhibits, but no transaction values, parties, or financial impacts are disclosed.

20-02-2026

Oramed Pharmaceuticals Inc. filed an 8-K on February 20, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or period-over-period comparisons are provided in the filing summary. This is a multi-item filing with no disclosed quantitative data or strategic context.

20-02-2026

Lamb Weston Holdings, Inc. filed an 8-K on 2026-02-20 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or financial impacts are disclosed.

• ·Filing Accession Number: 0001679273-26-000006
• ·Filing Size: 4 MB

20-02-2026

Carnival PLC filed an 8-K on 2026-02-20 reporting under Item 1.01 entry into a Material Definitive Agreement, with Item 9.01 disclosing Financial Statements and Exhibits. No quantitative metrics, transaction details, financial impacts, period-over-period comparisons, or other specifics such as dollar values, parties involved, or strategic context are disclosed.

20-02-2026

Velo3D, Inc. filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons for change, or timing are provided in the filing summary. No quantitative financial metrics, performance comparisons, or other material impacts are disclosed.

20-02-2026

ICU Medical Inc/DE filed an 8-K on 2026-02-20 disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, names of individuals, appointment or resignation status, reasons for the change, or any financial metrics are disclosed in the provided filing information. This appears to be a routine disclosure of a leadership-related event without additional quantitative or qualitative context.

20-02-2026

NovaBay Pharmaceuticals, Inc. filed an 8-K on February 20, 2026, disclosing under Item 3.03 material modifications to the rights of security holders and under Item 5.03 amendments to its articles of incorporation or bylaws or a change in fiscal year. Item 9.01 lists financial statements and exhibits. No specific details, financial impacts, or quantitative metrics regarding these changes are provided.

20-02-2026

Abony Acquisition Corp. I filed an 8-K on 2026-02-20 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, departures/elections/appointments of directors/officers and compensatory arrangements under Item 5.02, amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No quantitative metrics, deal terms, parties beyond the filer, or performance comparisons are disclosed. Sector is not specified.

20-02-2026

BKV Corp filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions affected, reasons for change, or compensation amounts are provided. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

20-02-2026

Encompass Health Corp filed an 8-K on 2026-02-20 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative impacts are disclosed. This is a routine SEC disclosure for leadership or governance changes with no further context provided.

• ·Event Type: Officer Change
• ·AccNo: 0000785161-26-000049
• ·File Size: 137 KB
• ·Sector: NOT_DISCLOSED

20-02-2026

Daktronics Inc. (/SD/) filed an 8-K on February 20, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for changes, or quantitative impacts are provided.

20-02-2026

Tyson Foods, Inc. filed a Form 8-K on 2026-02-20 reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative details such as transaction values, financial impacts, or period-over-period comparisons are disclosed. This is a multi-item filing with no positive or negative metrics provided.

20-02-2026

Aramark filed an 8-K on 2026-02-20 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Regulation FD Disclosure under Item 7.01. Specific details including the key position affected, individual names, appointment or resignation status, reasons, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material data points are provided.

20-02-2026

Proem Acquisition Corp. I filed an 8-K on 2026-02-20 (AccNo: 0001213900-26-018851, Size: 406 KB) disclosing under Item 1.01 entry into a material definitive agreement related to a merger/acquisition event. Item 9.01 covers financial statements and exhibits. No specific deal terms, parties, financial metrics, positive or negative performance indicators, or other quantitative details are disclosed.

20-02-2026

TriUnity Business Services Ltd filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 listing Financial Statements and Exhibits. No specific details on affected positions, individuals involved, reasons for the change, or compensatory terms are disclosed. Sector information is NOT_DISCLOSED.

20-02-2026

Rain Enhancement Technologies Holdco, Inc. filed an 8-K on February 20, 2026 (AccNo: 0001213900-26-018852), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, or additional details such as reasons for delisting, impacts, or sector context were disclosed. This event signals potential compliance or operational issues with no offsetting positive developments mentioned.

20-02-2026

Aveanna Healthcare Holdings, Inc. filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. Specific details including key positions affected, names of individuals, reasons for the change, timing, internal/external status, or any quantitative data are NOT_DISCLOSED.

20-02-2026

Phoenix Motor Inc. filed an 8-K on February 20, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for the change, or timing are disclosed. Sector is not specified.

20-02-2026

Averin Capital Acquisition Corp. filed an 8-K on 2026-02-20 announcing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, departure/election of directors or appointment of officers and compensatory arrangements under Item 5.02, and amendments to articles of incorporation or bylaws under Item 5.03, with additional other events under Item 8.01. No quantitative financial metrics, deal terms, parties involved, or performance comparisons are disclosed in the filing summary. Item 9.01 lists financial statements and exhibits, but specifics are NOT_DISCLOSED.

20-02-2026

Zurn Elkay Water Solutions Corp filed an 8-K on 2026-02-20 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). Item 9.01 discloses Financial Statements and Exhibits. No specific transaction details, dollar values, terms, positive or negative financial impacts, or other metrics are provided in the filing summary.

20-02-2026

Innventure, Inc. filed an 8-K on February 20, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics were disclosed.

20-02-2026

Ashford Hospitality Trust Inc filed an 8-K on February 20, 2026 (AccNo: 0001232582-26-000019), disclosing under Item 2.01 the completion of an acquisition or disposition of assets. No quantitative metrics, financial impacts, parties involved, deal value, or strategic rationale were mentioned in the provided filing summary. Sector was noted as not specified, limiting assessment of broader implications.

20-02-2026

Gabelli Multimedia Trust Inc. filed a Form 8-K on 2026-02-20 disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, events, or exhibits provided. No quantitative financial metrics, positive or negative changes, or performance comparisons are disclosed.

20-02-2026

Advantage Solutions Inc. filed an 8-K on 2026-02-20 disclosing an officer or director change under Item 5.02, covering departures, elections, appointments of certain officers, and compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific names, positions affected, reasons for change, financial metrics, or other quantitative details are disclosed.

20-02-2026

Jupiter Neurosciences, Inc. filed a Form 8-K on 2026-02-20 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative metrics, dollar values, strategic details, or performance comparisons are disclosed.

20-02-2026

Knowles Corp filed an 8-K on February 20, 2026, disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or quantitative data such as compensation amounts are disclosed.

20-02-2026

Solstice Advanced Materials Inc. filed an 8-K on February 20, 2026, reporting Item 5.08 regarding Shareholder Nominations Pursuant to Exchange Act Rule 14a-11 and Item 8.01 Other Events. No quantitative financial metrics, transaction values, period-over-period comparisons, or specific details on the nominations or events were disclosed. This multi-item filing provides governance-related information without directional financial impact.

20-02-2026

Idea Acquisition Corp. filed an 8-K on 2026-02-20 under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), labeled as a Merger/Acquisition event. No specific details on deal structure, parties involved, valuation, financial metrics, or strategic rationale were explicitly stated in the provided filing summary. All quantitative data and transaction specifics are NOT_DISCLOSED.

• ·AccNo: 0001104659-26-018207
• ·File size: 415 KB
• ·Sector: not specified

20-02-2026

RCI Hospitality Holdings, Inc. filed an 8-K on 2026-02-20 disclosing under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 9.01 reports Financial Statements and Exhibits. No financial metrics, transaction values, or specific reasons for the delisting are disclosed.

• ·AccNo: 0001628280-26-010283
• ·File size: 193 KB
• ·Event date: February 20, 2026

20-02-2026

Ventas, Inc. filed a Form 8-K on February 20, 2026, under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, or impacts are provided in the filing summary. No quantitative metrics, financial data, or performance comparisons are mentioned.

20-02-2026

Pasithea Therapeutics Corp. filed a Form 8-K on 2026-02-20 (AccNo: 0001213900-26-018874) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, revenue implications, or other quantitative data are disclosed. This event signals potential non-compliance with exchange listing requirements.

20-02-2026

TETRA TECH INC filed an 8-K on 2026-02-20 disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). Specific details regarding the officer change, such as position affected, appointment or resignation status, reasons, or vote outcomes, are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

20-02-2026

Stran & Company, Inc. filed an 8-K on 2026-02-20 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions affected, reasons for changes, or timing are provided in the available information. This represents a standard SEC disclosure for potentially material leadership events.

20-02-2026

SmartStop Self Storage REIT, Inc. filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics were disclosed.

20-02-2026

Nukkleus Inc. filed an 8-K on February 20, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions, reasons for changes, or other details are disclosed.

20-02-2026

Hydrofarm Holdings Group, Inc. filed an 8-K on February 20, 2026, disclosing under Item 1.02 the termination of a material definitive agreement, which typically carries negative strategic implications. Item 8.01 reports other events, but no further details on positive offsets, financial impacts, or context are provided.

20-02-2026

Bayview Acquisition Corp filed an 8-K on 2026-02-20 (AccNo: 0001493152-26-007621, Size: 266 KB) under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No transaction details, financial metrics, parties involved, or quantitative deal terms were disclosed. No positive or negative performance metrics were mentioned.

20-02-2026

Ovintiv Inc. filed an 8-K on February 20, 2026 (AccNo: 0001193125-26-061626), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on the key position affected, individuals involved, appointment or resignation status, reasons for the change, and any governance or succession planning implications are NOT_DISCLOSED. No quantitative data, financial metrics, scheduled events, or board outcomes are mentioned.

20-02-2026

Katapult Holdings, Inc. filed a Form 8-K on 2026-02-20 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits are included. No further details on the agreement, transaction value, parties, or financial impacts are disclosed.

• ·AccNo: 0000950103-26-002455
• ·File Size: 301 KB
• ·Sector: NOT_DISCLOSED

20-02-2026

Dine Brands Global, Inc. filed an 8-K on February 20, 2026 (AccNo: 0001193125-26-061624, Size: 140 KB) under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific executives, positions, reasons for changes, effective dates, or quantitative details are disclosed in the provided filing summary. This is an informational filing with no additional financial or operational metrics mentioned.

• ·Sector: not specified
• ·Event Type: Officer Change
• ·Critical missing information: specific executive names and titles, action type (appointment/resignation), reasons for change, effective dates, compensatory details, board composition impact

20-02-2026

CLOUDASTRUCTURE, INC. filed a Form 8-K on 2026-02-20 under Item 3.01 providing notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing. No quantitative financial metrics, transaction values, revenue impacts, or other details such as dollar amounts, percentages, or guidance changes were disclosed. This is a material regulatory event with no accompanying positive metrics reported.

• ·AccNo: 0001683168-26-001229
• ·File size: 197 KB
• ·Sector: NOT_DISCLOSED

20-02-2026

Community West Bancshares filed an 8-K on 2026-02-20 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for changes, or quantitative impacts are disclosed.